Man Group
EPZM

Man Group’s Epizyme, Inc EPZM Stock Holding History

Man Group’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-115,254
Closed -$84.7K – 1192
2022
Q1 		$133K Buy
+115,254
New +$188K ﹤0.01% 2021
2020
Q3 		– Sell
-348,514
Closed -$5.6M – 1914
2020
Q2 		$5.6M Buy
348,514
+323,871
+1,314% +$5.65M 0.03% 611
2020
Q1 		$382K Buy
+24,643
New +$529K ﹤0.01% 1340
2019
Q3 		– Sell
-17,653
Closed -$222K – 1974
2019
Q2 		$222K Buy
+17,653
New +$227K ﹤0.01% 1792
2019
Q1 		– Sell
-17,300
Closed -$107K – 2111
2018
Q4 		$107K Buy
+17,300
New +$132K ﹤0.01% 1852

Other funds holding EPZM

RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Man Group's EPZM Position: Q2 2022 in Review

Man Group sold out of Epizyme, Inc (EPZM) in Q2 2022, closing a stake of 115,254 shares — an estimated $84.7K sold.

Man Group first reported a position in EPZM in Q4 2018 and held it in 5 quarters. The position peaked at $5.6M in Q2 2020. 93 funds tracked by Wall St. Rank hold EPZM as of Q2 2022.

  • Man Group reported no remaining Epizyme, Inc position as of Q2 2022 after selling out during the quarter.
  • Man Group sold 115,254 Epizyme, Inc shares in Q2 2022, an estimated $84.7K.
  • Man Group first reported a position in Epizyme, Inc in Q4 2018 and held it in 5 quarters.
  • Man Group's Epizyme, Inc position peaked at $5.6M in Q2 2020.
  • 93 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2022.

Based on Man Group's 13F filing for Q2 2022, filed 15 Aug 2022.